1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 467 F.Supp.2d
  5. 467 F.Supp.2d 74 (2006)
 

IN RE LORAZEPAM & CLORAZEPATE ANTITRUST LITIGATION

No. MDL 1290.

467 F.Supp.2d 74 (2006)

In re LORAZEPAM & CLORAZEPATE ANTITRUST LITIGATION This Opinion applies to: All Actions

United States District Court, District of Columbia.

December 20, 2006.

MEMORANDUM OPINION

THOMAS F. HOGAN, Chief Judge.

Pending before the Court are several post-trial motions. Defendant Mylan Laboratories, Inc., Defendant Mylan Pharmaceuticals, Inc. (together, "Mylan"), Defendant Cambrex Corporation ("Cambrex"), and Defendant Gyma Laboratories of America, Inc. ("Gyma"), collectively ("Defendants"), filed the following post-trial motions: Defendants' Renewed Motion for Judgment...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases